Crinetics Pharmaceuticals, Inc. Derivative Asset
Crinetics Pharmaceuticals, Inc. (CRNX) had Derivative Asset of $0 as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet
us-gaap:DerivativeAssets · last filed 2024-02-28
- 2023-12-31: Derivative Asset $0.00.
- 2023-09-30: Derivative Asset $0.00.
- 2023-06-30: Derivative Asset $668.00K.
- 2023-03-31: Derivative Asset $668.00K.
| Period end | Derivative Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2023-06-30 | $668.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $668.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $668.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $99.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $99.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $68.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $68.00K 10-K · filed 2023-02-28 |